Alnylam Pharmaceuticals | Los Gastos Financieros De La Deuda



Interest Expense On Debt Cambio Fecha
Acadia Pharmaceuticals 0 4.12M 2024-09
Agios Pharmaceuticals 3.01M 10.05M 2024-12
Alnylam Pharmaceuticals USD 38.65M 325K 2025-03
Amgen USD 723M 24M 2025-03
Arrowhead Research USD 21.65M 7M 2024-12
BioMarin Pharmaceutical USD 2.86M 286K 2025-03
Incyte USD 660K 241K 2025-03
Ionis Pharmaceuticals USD 19M 16.41M 2025-03
Moderna USD 1000K 5M 2025-03
Neurocrine Biosciences USD 1.1M 0 2024-03
Novartis USD 275M 11M 2024-12
PTC Therapeutics USD 43.35M 1.24M 2024-12
Regeneron Pharmaceuticals USD 8.7M 1.8M 2025-03
Sanofi 66.11M 20.67M 2024-12
Sarepta Therapeutics USD 4.92M 86K 2024-09
Takeda 31.6B 36.86B 2024-12
Tectonic Therapeutic USD 22K 3K 2024-12
Ultragenyx Pharmaceutical 15.52M 190K 2024-12
Vertex Pharmaceuticals USD 2.8M 4.7M 2024-12
Xencor -39359000 40.15M 2024-12



Alnylam Pharmaceuticals Los Gastos Financieros De La Deuda - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.